Screening for celiac disease in the general population and in high-risk groups
BACKGROUND: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. OBJECTIVES: To review the literature on screening for CD in relation to the curre...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Published: |
SAGE
2014
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/35870/ |
| _version_ | 1848795179821039616 |
|---|---|
| author | Ludvigsson, Jonas F. Card, Timothy R. Kaukinen, Katri Bai, Julio Zingone, Fabiana Sanders, David S. Murray, Joseph A. |
| author_facet | Ludvigsson, Jonas F. Card, Timothy R. Kaukinen, Katri Bai, Julio Zingone, Fabiana Sanders, David S. Murray, Joseph A. |
| author_sort | Ludvigsson, Jonas F. |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | BACKGROUND: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death.
OBJECTIVES: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening.
METHODS: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail.
RESULTS: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective.
CONCLUSIONS: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups. |
| first_indexed | 2025-11-14T19:27:59Z |
| format | Article |
| id | nottingham-35870 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T19:27:59Z |
| publishDate | 2014 |
| publisher | SAGE |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-358702020-05-04T16:58:33Z https://eprints.nottingham.ac.uk/35870/ Screening for celiac disease in the general population and in high-risk groups Ludvigsson, Jonas F. Card, Timothy R. Kaukinen, Katri Bai, Julio Zingone, Fabiana Sanders, David S. Murray, Joseph A. BACKGROUND: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. OBJECTIVES: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. METHODS: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. RESULTS: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. CONCLUSIONS: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups. SAGE 2014-12-18 Article PeerReviewed Ludvigsson, Jonas F., Card, Timothy R., Kaukinen, Katri, Bai, Julio, Zingone, Fabiana, Sanders, David S. and Murray, Joseph A. (2014) Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterology Journal, 3 (2). pp. 106-120. ISSN 2050-6414 Celiac disease gluten gluten-free diet review screening prevention risk quality of life World Health Organization http://ueg.sagepub.com/content/3/2/106 doi:10.1177/2050640614561668 doi:10.1177/2050640614561668 |
| spellingShingle | Celiac disease gluten gluten-free diet review screening prevention risk quality of life World Health Organization Ludvigsson, Jonas F. Card, Timothy R. Kaukinen, Katri Bai, Julio Zingone, Fabiana Sanders, David S. Murray, Joseph A. Screening for celiac disease in the general population and in high-risk groups |
| title | Screening for celiac disease in the general population and in high-risk groups |
| title_full | Screening for celiac disease in the general population and in high-risk groups |
| title_fullStr | Screening for celiac disease in the general population and in high-risk groups |
| title_full_unstemmed | Screening for celiac disease in the general population and in high-risk groups |
| title_short | Screening for celiac disease in the general population and in high-risk groups |
| title_sort | screening for celiac disease in the general population and in high-risk groups |
| topic | Celiac disease gluten gluten-free diet review screening prevention risk quality of life World Health Organization |
| url | https://eprints.nottingham.ac.uk/35870/ https://eprints.nottingham.ac.uk/35870/ https://eprints.nottingham.ac.uk/35870/ |